Austar Lifesciences Limited (HKG:6118)

Austar Lifesciences Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 3, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	374	292	800	1,035	7,730	3,122
Market Cap Growth	23.73%	-63.46%	-22.77%	-86.61%	147.62%	17.79%
Enterprise Value	585	630	1,072	1,131	7,454	3,044
Last Close Price	0.73	0.57	1.56	2.02	15.08	6.09
PE Ratio	9.70	17.08	-	10.47	22.71	79.41
Forward PE	-	4.80	4.80	4.80	4.80	4.80
PS Ratio	0.23	0.18	0.41	0.43	3.13	2.03
PB Ratio	0.42	0.35	0.94	1.04	7.99	5.01
P/TBV Ratio	0.44	0.37	0.99	1.09	8.23	5.32
P/FCF Ratio	3.71	3.51	-	-	-	102.34
P/OCF Ratio	2.89	2.78	-	-	-	50.33
PEG Ratio	-	0.21	0.21	0.21	0.21	0.21
EV/Sales Ratio	0.37	0.39	0.55	0.46	3.01	1.98
EV/EBITDA Ratio	6.30	9.10	-	7.30	46.49	64.36
EV/EBIT Ratio	14.17	17.02	-	8.15	51.92	97.17
EV/FCF Ratio	5.80	7.56	-	-	-	99.81
Debt / Equity Ratio	0.44	0.51	0.64	0.38	0.20	0.15
Debt / EBITDA Ratio	4.32	4.89	-	2.15	1.06	1.36
Debt / FCF Ratio	3.88	5.13	-	-	-	2.98
Net Debt / Equity Ratio	0.24	0.30	0.42	0.21	-0.08	-0.19
Net Debt / EBITDA Ratio	2.87	3.60	-16.27	1.38	-0.49	-2.55
Net Debt / FCF Ratio	2.08	2.99	-2.44	-1.22	0.32	-3.96
Asset Turnover	0.70	0.71	0.78	0.97	1.18	1.01
Inventory Turnover	4.86	4.98	4.52	4.11	4.86	5.22
Quick Ratio	1.05	1.00	1.01	0.86	0.81	0.87
Current Ratio	1.37	1.31	1.34	1.32	1.46	1.35
Return on Equity (ROE)	4.15%	1.73%	-4.19%	12.04%	41.53%	6.15%
Return on Assets (ROA)	1.07%	1.02%	-1.13%	3.46%	4.27%	1.29%
Return on Invested Capital (ROIC)	2.77%	2.10%	-3.80%	11.51%	17.42%	5.07%
Return on Capital Employed (ROCE)	3.80%	3.90%	-4.20%	11.90%	12.90%	4.60%
Earnings Yield	10.31%	5.86%	-15.63%	9.55%	4.40%	1.26%
FCF Yield	26.95%	28.52%	-18.17%	-16.93%	-3.24%	0.98%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.